lifestyle.newsblaze.com

Author: Entera Bio

Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates

March 27, 2026
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis

March 4, 2026
Entera Bio Announces Open Market Purchases of Company Stock by Board Members

February 13, 2026
Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones

February 12, 2026
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

February 10, 2026
Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook

January 21, 2026